4//SEC Filing
Narula Sanjeev 4
Accession 0000950170-24-097292
CIK 0001567514other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:01 PM ET
Size
7.7 KB
Accession
0000950170-24-097292
Insider Transaction Report
Form 4
Narula Sanjeev
Executive Vice President & CFO
Transactions
- Award
Restricted Stock Units
2024-08-12+35,046→ 35,046 total→ Common Stock (35,046 underlying) - Award
Stock Option (right to buy)
2024-08-12+17,251→ 17,251 totalExercise: $74.90Exp: 2034-08-11→ Common Stock (17,251 underlying)
Footnotes (3)
- [F1]The option vests as to one third of the shares on August 12, 2025, one third of the shares on August 12, 2026 and one third of the shares on August 12, 2027.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The restricted stock units vest as to one third of the shares on August 12, 2025, one third of the shares on August 12, 2026 and one third of the shares on August 12, 2027.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001820590
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:01 PM ET
- Size
- 7.7 KB